Spark Investment Management LLC Concert Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$7.8 - $11.52 $136,500 - $201,600	-17,500 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$5.98 - $13.09 $104,650 - $229,075	17,500 New	17,500 $154,000
Q4 2018 Feb 12, 2019	SELL	$11.25 - $16.17 $633,341 - $910,322	-56,297 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$12.82 - $17.88 $524,376 - $731,345	-40,903 Reduced 42.08%	56,297 $835,000
Q2 2018 Aug 08, 2018	SELL	$16.83 - $21.66 $797,741 - $1.03 Million	-47,400 Reduced 32.78%	97,200 $1.64 Million
Q1 2018 May 10, 2018	BUY	$19.24 - $28.03 $2.78 Million - $4.05 Million	144,600 New	144,600 $3.31 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.